Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Effectiveness in Oral Rhus toxicodendron Solution for Poison Ivy Prevention

Author(s):  Stein Michael F, Parsons Eric

Issue:  Jul/Aug 2003 - After the Women's Health Initiative Trial
View All Articles in Issue

Page(s):  272-275

Effectiveness in Oral Rhus toxicodendron Solution for Poison Ivy Prevention Page 1
Effectiveness in Oral Rhus toxicodendron Solution for Poison Ivy Prevention Page 2
Effectiveness in Oral Rhus toxicodendron Solution for Poison Ivy Prevention Page 3
Effectiveness in Oral Rhus toxicodendron Solution for Poison Ivy Prevention Page 4

Download in electronic PDF format for $75

Abstract:  This article reviews the effects of an oral solution of Rhus toxicodendron extract taken by patients during 2002 for prevention of contact allergic dermatitis. The solution used in this study was a concentration of 0.0001% Rhus toxicodendron (6X/12X) A sublingual dose of 3 mL was given on day 0, day 7 and day 14, followed by a maintenance dose of 3 mL, given at monthly intervals for 7 more doses. Instructions were to hold the solution under the tongue for 30 seconds and to swallow any remaining solution. Therapy was to be initiated before March and continued through September (although this did not always occur). A total of 73 patients were prescribed the oral solutions, 58 of whom could be contacted for follow-up. Two of these had not had a poison-ivy reaction in he previous year and so were excluded from the results. Of the remaining 56 patients, 25 (44.6%) had no poison-ivy reaction for the year with the oral solution. An additional 27 (48.2%) either reported a reaction that was less severe or reported fewer poison-ivy reactions for the year with the oral solution. Of the 58 patients, 56 (96.6%) said they would use the product again, 54 (93.1%) said they would recommend the product to a family member or friend, and 54 (93.1%) said they would recommend to their physician that he or she prescribe this medication for other patients. Only one patient reported mild facial flushing. The authors conclude that a dilute solution of Rhus toxicodendron dosed orally shows promise as an effective method for controlling reactions caused by poison ivy, poison oak and poison sumac, with 52 of 56 patients reporting reduced severity in symptoms associated with allergic contact dermatitis.

Related Keywords: Contact allergic dermatitis, poison ivy, prevention of, Contact dermatitis, poison ivy, prevention of, Poison ivy, prevention of, Rhus toxicodendron, in the prevention of poison ivy

Related Categories: DERMATOLOGY, ENVIRONMENTAL

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Effectiveness in Oral Rhus toxicodendron Solution for Poison Ivy Prevention
Stein Michael F
, Parsons Eric
Jul/Aug 2003
Pg. 272-275

Treating Patients Allergic to Poison Ivy
Karolchyk Scott
Nov/Dec 1998
Pg. 421

Poison Ivy Extract Injection (10-mcg/mL)
Karolchyk Scott
Nov/Dec 1998
Pg. 421

Poison Ivy Gel with 1% Hydrocortisone
Allen Loyd V Jr
Jan/Feb 2001
Pg. 50

Compounded Melatonin Cream for the Prevention and Treatment of Radiation Dermatitis: A Case Report
Garcia-Segura Laura Corral
, Garcia-Segura Javier Corral, Delgado Carlos Dorado, Maldonaldo Nuria Romero, Salgado Elena Cardero, Llorens Lucía Pérez
Jan/Feb 2022
Pg. 6-8

Pediatric Dermatitis
Remmert Renee
Nov/Dec 2002
Pg. 419-421

Case Report: Hydroxyprogesterone Caproate Injection for Prevention of Preterm Labor
Fields Shannon W
May/Jun 2006
Pg. 172

Migraine: A General Approach to Prevention and Treatment
Kennedy Bonnie M
Sep/Oct 2006
Pg. 344-350

Quality Assurance: Compounding Record Audits for Error Prevention
Hawkins Jessica
May/Jun 2023
Pg. 211-217

Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
Mar/Apr 2021
Pg. 131-139

Canine Methylpyrazole Solution for Ethylene Glycol Poisoning
Allen Loyd V Jr
Jul/Aug 1997
Pg. 255

Dimercaptosuccinic Acid: Summary of Evidence
Carvin Jamarius
, Thompson Tara
Mar/Apr 2023
Pg. 94-96

Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
May/Jun 2021
Pg. 222-229

The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 1
Williams LaVonn
Jul/Aug 2018
Pg. 284-287

The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2
Williams LaVonn A
Jan/Feb 2019
Pg. 14-21

Child-safety Containers/Devices and Compounding
Allen Loyd V Jr
Sep/Oct 2017
Pg. 364-370

Estrogen in the Treatment and Prevention of Alzheimer's Disease
Paganini-Hill Annlia
, Henderson Victor W
Jan/Feb 1998
Pg. 24-29

Xylitol in the Prevention of Otitis Media
Glasnapp Andrew
May/Jun 2000
Pg. 171-174

An Ounce of Prevention: Controlling Hazards in Extemporaneous Compounding Practices
Kastango Eric S
, Trissel Lawrence A, Bradshaw Brian D
Sep/Oct 2003
Pg. 401-416

Prevention Is the Best Medicine: Don J. Bottoni, RPh, FACA, FIACP
Bottoni Don J
Jan/Feb 2004
Pg. 22-27

Return to Top